The traditionally conservative Jinteki corporation is now being led by an aggressive new chairman of the board, Chairman Hiro, through a series of upheavals and transitions.
Alongside rapid developments in the field of cloning and biotechnology in the last decade, the corporation has relocated its headquarters from Tokyo, Japan to New Angeles, acquired or built laboratories on Mars, and shifted its recruitment policies to diversify its research and sales forces. Branch offices have also been granted more autonomy and localized marketing has increased sales of consumer-model clones (though most clone sales are still business-to-business). This upheaval mirrors unrest in society at large in the past decades, and the cause is the same: androids.
Jinteki owns the patent on the process that creates humanlike clones, biological androids tailor-made by the “genegineers” of Jinteki. As this controversial technology becomes cheaper and more robust, more and more humans find themselves replaced in the workforce by cheaper android labor. While some Jinteki corporation products (such as the vacuum-tolerant “turtleback” clones sometimes seen in Heinlein or on the Beanstalk) bear only a faint resemblance to human beings, others are virtually indistinguishable, marked only by barcode tattoos on the backs of their necks.
Jinteki markets its clones as more personable and person-like than the robotic bioroids built by their chief competitor. Clones are inherently adaptable and intuitive, just like a real person, and are able to establish empathy with real humans more easily than other androids. They excel in service industry positions, although heavy-labor and industrial-process clones are also readily available. Rumors exist of clone projects that explore the potential of human psionic ability, but such claims are dismissed by serious scientists. Jinteki has performed extensive research on the human brain and mind-machine interface technologies, but this is because so-called “braintaping” technology is essential to their production process.
The new, sleeker, more modern Jinteki prides itself on adaptability, aesthetics, and a connection to the natural world. Jinteki is proud of its heritage as a Japanese corporation and embraces a traditional aesthetic as part of its corporate identity. In addition to clones, Jinteki and its subsidiaries specialize in biotechnology, cloned organs, pharmacology, agriculture, and medical equipment.